A one-time injection of a gene therapy has shown promise in slowing the progression of Huntington's disease, with reports suggesting a significant reduction in disease progression. The treatment, which has been tested in a trial, appears to have been successful in slowing the disease, although some outlets describe the results as preliminary. The extent of the slowing effect is reported to be around 75 percent, although details of the trial and its outcomes are not fully specified.